http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2342107-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb60efcd409a297ec3c2f823da6a228b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af089d092b67237d7d12a0cbf1b1c5c7
publicationDate 2008-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2342107-C1
titleOfInvention Elimination method of upper eyelid retraction in case of anophthalmus
abstract FIELD: medicine; ophthalmology. n SUBSTANCE: in case of conjunctival cavity deformation and deficiency of orbit soft tissues, stabilised hyaluronic acid of non-animal origin is injected consistently by one injection in the external, medium and internal third of the upper orbit osteal edge. Thus a skin puncture is made at angle of 45 degrees, parallel to uper orbit osteal edge, up to periosteum and orbicularis muscle depth. In one injection 0.3-0.5 ml (6-10 mg) of the preparation is brought in. After preparation papule injection it is spread mechanically evenly along the upper orbit osteal edge. n EFFECT: simplification of operation technique and avoidance of implant excision which has been introduced before, possibility to avoid a casting-off, inflammatory reactions and expansion of an arsenal of means for anophthalmic syndrome correction. n 2 cl, 2 ex
priorityDate 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914

Total number of triples: 14.